Abstract
We report a case of a 35-year-old male, with a history of diarrhea, renal lithiasis with frequent expulsions of calculus and hypercalcemia during the last 2 years. The patient was studied and diagnosed with a multiple endocrine neoplasia type I (MEN I), familiar (mother with MEN I). A scintigraphic study with 99mTc-MIBI was performed in order to localize hyperfunctioning parathyroid glands because of biochemical diagnosis of primary hyperparathyroidism. Double phase 99mTc-MIBI scan detected one hyperfunctioning parathyroid gland and a large anterior mediastinal mass. Subsequent, plain radiograph and CT of the chest showed a soft-tissue mass in that localization. Punch biopsy of the lesion guided by CT revealed malignant cells of neuroendocrine tumor. The tumor was removed and histologically confirmed as a carcinoid within a thymus in a MEN type I syndrome. MEN I patients can benefit from the examination with this agent which can potentially localize not only parathyroid endocrine pathology but also unknown associated tumors.
Similar content being viewed by others
References
Holman B.L., Jones A.G., Lister-James J., Davidson A., Abrams M.J., Kirshenbaum J.M., Tumeh S.S., English R.J. A new Tc-99m-labeled myocardial imaging agent, hexakis (t-butylisonitrile) technetium(I) [Tc-99mTBI], initial experience in the human. J. Nucl. Med. 1984, 25: 1350–1355.
Wackers F.J.T., Berman D.S., Maddahi J., Watson D.D., Beller G.A., Strauss H.W., Boucher C.A., Picard M., Holman B.L., Fridrich R. Technetium-99m hexakis 2-methoxy-isobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J. Nucl. Med. 1989, 30: 301–311.
Chiu M.L., Kronauge J.F., Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J. Nucl. Med. 1990, 31: 1646–1653.
Delmon-Moingeon L.I., Piwnica-Worms D., Van den Abbeele A.D., Holman B.L., Davison A., Jones A.G. Uptake of the cation hexakis (2-methoxisobutylisonitrile)- technetium-99m by human carcinoma cell lines in vitro. Cancer Res. 1990, 50: 2198–2202.
Stefanescu C., Rusu V., Maublant J.C. An in-vitro study of 99mTc-sestamibi uptake by normal and neoplastic cell lines. Rev. Med. Chir. Soc. Med. Nat. Iasi 1995, 99: 116–123.
Chen L.B. Mitochondrial membrane potentials in living cells. Ann. Rev. Cell. Biol. 1988, 4: 155–181.
Aktolun C., Bayhan H., Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with TI-201. Clin. Nucl. Med. 1992, 17: 171–176.
Beller G.A., Watson D.D. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin. Nucl. Med. 1991, 21: 173–181.
Coakley A.J., Kettle A.G., Wells C.P., O’Doherty M.J., Collins R.E.C. Tc-99m sestamibi — a new agent for parathyroid imaging. Nucl. Med. Commun. 1989, 10: 791–794.
O’Doherty M.J., Kettle A.G., Wells P., Collins R.E., Coackley A.J. Parathyroid imaging with technetium 99m-sestamibi: preoperative localization and tissue uptake studies. J. Nucl. Med. 1992, 33: 313–318.
Taillefer R., Boucher Y., Potvin C., Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium- 99m sestamibi (double-phase study). J. Nucl. Med. 1992, 33: 1801–1807.
Gagel R.F. Multiple endocrine neoplasia. In: Wilson J., Foster D. (Eds.), Williams Texbook of Endocrinology, ed. 8. W.B. Saunders, Philadelphia, PA, 1992, p. 1537.
Leshin M. Multiple endocrine neoplasia. In: Wilson J., Foster D. (Eds.), Williams Textbook of Endocrinology, ed. 7. W.B. Saunders, Philadelphia, PA, 1989, p. 1274.
Benson L., Ljunghall S., Akerstrom G., Oberg K. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type I. Am. J. Med. 1987, 82: 731–737.
Skogseid B., Eriksson B., Lundquist G., Lorelius L.E., Rastad J., Wide L., Akerstrom G., Oberg K. Multiple endocrine neoplasia Type I: a 10-year prospective screening study in four kindreds. J. Clin. Endocrinol. Metab. 1991, 73: 281–287.
Van heerden J.A., KENT R.B. III, Sizemore G.W., Grant C.S., ReMine W.H. Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Arch. Surg. 1983, 118: 533–536.
Underdahl L.O., Woolner L.B., Black B.M. Multiple endocrine adenomas. Report of 8 cases in which the parathyroid, pituitary and pancreatic islets were involved. J. Clin. Endocrinol. Metab. 1953, 13: 20–47.
Duh Q.Y., Hybarger C.P., Geist R., Gamsu G., Goodman P.C., Gooding G.A., Clark O.H. Carcinoid associated with multiple endocrine neoplasia syndromes. Am. J. Surg. 1987, 154: 142–148.
Zeiger M.A., Swartz S.E., MacGillivray D.C., Linnoila I., Shakir M. Thymic carcinoid in association with MEN syndromes. Am. Surg. 1992, 58: 430–434.
Asbun H.J., Calabria P.P., Calmes S., Lang A.G., Bloch J.H. Thymic carcinoid. Am. Surg. 1991, 57: 442–445.
Campeau R.J., Kronemer K.A., Sutherland C.M. Concordant uptake of the Tc-99m sestamibi and TI-201 in unsuspected breast tumor. Clin. Nucl. Med. 1992, 17: 936–937.
Strouse P.J., Wang D.C. Incidental detection of bronchogenic carcinoma during Tc-99m sestamibi cardiac imaging. Clin. Nucl. Med. 1993, 18: 448–449.
Kitapci M.T., Tastekin G., Turgut M., Caner B., Kars A., Barista I., Bekdik C. Preoperative localization of parathyroid carcinoma using Tc-99m MIBI. Clin. Nucl. Med. 1993, 18: 217–218.
O’Driscoll C.M., Baker F., Casey M.J., Duffy G.J. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoisobutylnitrile scintigraphy: a case report. J. Nucl. Med. 1991, 32: 2281–2283.
Vattimo A., Bertelli P., Cintorino M., Burrino L., Volterrani D., Vella A., Lazzi S. HurthIe cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy. J. Nucl. Med. 1998, 39: 822–825.
Stefanescu C., Meignan M., Rusu V. The value of scintigraphic imaging with 99mTc-MIBI for the diagnosis of gliomas. Rev. Med. Chir. Soc. Med. Nat. Iasi. 1995, 99: 99–107.
Pui M.H., Du J.Q., Yueh T.C., Zeng S.Q. Imaging of nasopharyngeal carcinoma with Tc-99m MIBI. Clin. Nucl. Med. 1998, 23: 29–32.
Robinson D., Pinkas L., Mindlin L., Halperin N., Horn T. Technetium 99mTc-sestamibi bone scan in musculo- skeletal neoplasms. Harefuah 1997, 133: 509–514.
Bom H.S., Kim Y.C., Song H.C., Min J.J., Kim J.Y., Park K.O. Technetium-99m-MIBI uptake in small cell lung cancer. J. Nucl. Med. 1998, 39: 91–94.
Grunwald F., Menzel C., Bender H., Palmedo H., WilIkomm P., Ruhlmann J., Franckson T., Biersack H.J. Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 1997, 7: 327–335.
Perez-Monte J.E., Brown M.L., Clarke M.R., Watson C.G., Carty S.E. Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with Technetium-99m-MIBI in MEN type I. J. Nucl. Med. 1997, 38: 1767–1769.
Bernà LI. 99mTc-sestamibi en el diagnóstico de localización del hiperparatiroidismo. Rev. Esp. Med. Nucl. 1998, 17: 102–111.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marí, C., León, J., Farrerons, J. et al. Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1. J Endocrinol Invest 22, 803–807 (1999). https://doi.org/10.1007/BF03343648
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343648